These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1541058)

  • 1. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
    Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
    Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
    Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
    Grotz W; Wanner C; Keller E; Böhler J; Peter HH; Rohrbach R; Schollmeyer P
    Clin Nephrol; 1991 Jun; 35(6):243-51. PubMed ID: 1873937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis.
    de Glas-Vos JW; Krediet RT; Arisz L
    Neth J Med; 1991 Apr; 38(3-4):96-103. PubMed ID: 1881508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
    Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA; Lohavichan V; Hennigar R
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crescentic glomerulonephritis in Behçet's syndrome--results of therapy and review of the literature.
    Donnelly S; Jothy S; Barré P
    Clin Nephrol; 1989 Apr; 31(4):213-8. PubMed ID: 2714026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
    Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
    Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
    Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment and prognosis of rapidly progressive glomerulonephritis.
    Keller F; Oehlenberg B; Kunzendorf U; Schwarz A; Offermann G
    Clin Nephrol; 1989 Apr; 31(4):190-7. PubMed ID: 2714023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
    Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of methylprednisolone pulse therapy in the insidious type of crescentic glomerulonephritis].
    Takeda S; Kida H; Takazakura E; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):490-6. PubMed ID: 9379560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.